Tagged With Pharmaceutical

'Pharma Bro' Martin Shkreli had $7 million of his assets seized when he was sent to prison -- and people are arguing over who gets the first slice


3 VA employees were just indicted over charges they accepted bribes from the 'Trump of Georgia's' pharmaceutical firm


A depression drug that researchers have called 'the most important discovery in half a century' just got a big lift



Ketamine could become the first new depression drug in more than 30 years


Teva Pharmaceuticals soars after Warren Buffett's Berkshire Hathaway discloses a stake


Juno Therapeutics jumps 53% after report Celgene is interested in buying the cancer drugmaker



DIGITAL HEALTH BRIEFING: Viant, GSK partner for blockchain in pharmaceuticals --  CMS moves to increase the use of digital health solutions -- Hospitals to save big from teleservices


DIGITAL HEALTH BRIEFING: Top trends from HealthConf 2017 -- FDA set to change genetic health risk test regulations -- Australia strengthens digital health record system


Wall Street's most hated drugmaker is getting annihilated after a bizarre conference call


Amazon is making noise in pharma these days -- here's what it could all mean


A furious employee is suing Wall Street's most hated pharma stock over claims about its blockbuster drug


A furious employee is suing drugmaker Mallinckrodt over claims about its $38,000-a-dose blockbuster



Explosive leaked audio reveals the moment a drug company lied about a patient having cancer to get them opioids


Mallinckrodt is getting crushed after a judge invalidated many of its patents


A popular herbal supplement can interfere with many medications, including birth control


Shares in drug maker Indivior tanked almost 40% after losing its heroin treatment copyright case



ANALYST: Most investors respect the Merck CEO's decision to resign from Trump's council


Things are finally really starting to hurt for the maker of EpiPen


One of Trump's best sounding proposals to control drug pricing is a total dud


There's frightening new data on the effects of a blockbuster drug Wall Street loves to hate